TY - JOUR
AU - E. E. Krans
AU - S. W. Patrick
A1 - 
AB - Opioid abuse among pregnant women has reached epidemic proportions and has influenced maternal and child health policy at the federal, state, and local levels. As a result, we review the current state of opioid use in pregnancy and evaluate recent legislative and health policy initiatives designed to combat opioid addiction in pregnancy. We emphasize the importance of safe and responsible opioid-prescribing practices, expanding the availability and accessibility of medication-assisted treatment and standardizing care for neonates at risk of neonatal abstinence syndrome. Efforts to penalize pregnant women and negative consequences for disclosing substance use to health care providers are harmful and may prevent women from seeking prenatal care and other beneficial health care services during pregnancy. Instead, health care providers should advocate for health policy informed by scientific research and evidence-based practice to reduce the burden of prenatal opioid abuse and optimize outcomes for mothers and their neonates.
BT - Obstetrics and gynecology
C5 - Opioids & Substance Use; Healthcare Policy
CP - 1
CY - United States
DO - 10.1097/AOG.0000000000001446
IS - 1
JF - Obstetrics and gynecology
N2 - Opioid abuse among pregnant women has reached epidemic proportions and has influenced maternal and child health policy at the federal, state, and local levels. As a result, we review the current state of opioid use in pregnancy and evaluate recent legislative and health policy initiatives designed to combat opioid addiction in pregnancy. We emphasize the importance of safe and responsible opioid-prescribing practices, expanding the availability and accessibility of medication-assisted treatment and standardizing care for neonates at risk of neonatal abstinence syndrome. Efforts to penalize pregnant women and negative consequences for disclosing substance use to health care providers are harmful and may prevent women from seeking prenatal care and other beneficial health care services during pregnancy. Instead, health care providers should advocate for health policy informed by scientific research and evidence-based practice to reduce the burden of prenatal opioid abuse and optimize outcomes for mothers and their neonates.
PP - United States
PY - 2016
SN - 1873-233X; 0029-7844
SP - 4
EP - 10
EP - 
T1 - Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic
T2 - Obstetrics and gynecology
TI - Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic
U1 - Opioids & Substance Use; Healthcare Policy
U2 - 27275812
U3 - 10.1097/AOG.0000000000001446
VL - 128
VO - 1873-233X; 0029-7844
Y1 - 2016
ER -